Search

An interview with Deepak Chopra, a renowned thinker, author, and philosopher is presented. He shares his perspectives on the therapeutic potential of psychedelics, the impact of technology on human health, the use of cannabis for inflammation and mental health, and the nature of consciousness. He further aims to explore insights and opinions on these subjects, offering readers a glimpse into his unique perspective on the intersection of science, spirituality, and medicine.

The article discusses how libraries can provide information and support to entrepreneurs in the cannabis industry. Topics include impact of the legalization of marijuana in many states and municipalities on the legal industry and budding entrepreneurs, the role of libraries in helping entrepreneurs parse the complicated regulations of the cannabis industry, and challenges brought by the fraught history of cannabis sales in the U.S. for libraries providing services in this area.

The article offers information on the international Intoxicating Cannabinoid Product Symbol (IICPS), a universally designed symbol that several states have adopted as of 2023. Topics discussed include the importance of standardization, the process and rules of standardization, and the problems with most cannabis symbols.

Cannabis for medicinal use was legalised in the UK in 2018, following a campaign spearheaded by parents of children with epilepsy whose life-threatening seizures dissipated after taking cannabis oil. The change in legislation made cannabis-based products for medicinal use (CBPMs) schedule 2 controlled drugs. Drugs in this category have therapeutic value but are strictly controlled and subject to special requirements relating to their prescription, dispensing, recording and safe custody. [ABSTRACT FROM AUTHOR]

The article focuses on the challenges faced by hemp farmers in South Carolina since the legalization of hemp cultivation in 2018. Topics discussed include the oversaturation of the Cannabidiol (CBD) market, disappointed growers, successful industrial hemp farming, and the potential for legalizing medical marijuana in the state.

The article provide information and considerations for individuals in deciding which method of ingesting medical marijuana is suitable for them. It highlights the importance of self-awareness, including factors such as prior experience with cannabis, sensitivity to smoking, and metabolism, in making this decision. It also emphasizes the significance of knowing the types of cannabis products permitted by the state government.

The article focuses on the lack of discussion and marketing surrounding the effects of cannabis on libido, orgasm, and sexual satisfaction. It highlights the scientific evidence supporting the idea that cannabis can enhance sexual enjoyment and function. It argues that while many cannabis brands focus on marketing the plant for sleep or pain relief, there is a need for more products that speak to the sexual effects of cannabis.

A personal narrative is presented which explores the author's experiences with injuries, pain management, and their perspectives on the use of cannabis as an alternative to pharmaceutical painkillers.

The article focuses on the metrics and numbers surrounding the use of medical cannabis in the U.S., challenging the notion that it has "no accepted medicinal use" and highlighting its widespread adoption for health, wellness, and various medical purposes.

The article focuses on the growing demand for cannabis products formulated for animals, particularly Cannabidiol (CBD), and their potential benefits for pets. It highlights the increasing interest among pet owners in using CBD to treat various issues such as separation anxiety, chronic pain, and seizures in their furry companions. It also mentions studies that has shown the potential of CBD in easing symptoms of osteoarthritis and reducing seizure activity in dogs.

The article focuses on the growing momentum of adult-use cannabis legalization in Europe and its potential impact on medical cannabis patients. It emphasizes the importance of advocating for safe access and sensible medical cannabis policies to ensure that patients needs are not overlooked amidst the focus on adult-use legalization. It also discusses the potential positive effects of adult-use legalization on medical cannabis access in other jurisdictions, including Spain and Germany.

An introduction is presented in which the editor discusses articles in the issue on topics including the medical benefits of cannabis, the movement to legalize cannabis and the latest products and accessories for cannabis enthusiasts.

The article focuses on the author's personal journey of incorporating cannabis into daily cooking through innovative cannabis-infused spice blends called Herb + Spice, which adds both flavor and therapeutic benefits to dishes. It mentions the blends are designed to work harmoniously with the flavors of food while providing a pure form of THC and CBD ingestion.

The article focuses on the Cannabis Clock, a countdown to federal legalization of cannabis, providing updates on the progress at both state and federal levels. It discusses various state-level developments, including California's challenges with a cannabis pathogen, Maryland's impressive sales figures and social equity commitment, Delaware's legalization without the governor's signature, Minnesota's tribal nation-owned dispensary.

The article focuses on the partnership between ACS Laboratory and Blockticity, which leverages blockchain technology to create a transparent and secure certificate of authenticity (COA) verification process for the cannabis and hemp industries. Topics discussed include the benefits of blockchain technology in ensuring transparency, enhancing supply chain traceability, and protecting data integrity, as well as its potential to transform certification systems in various industries.

The article discusses how Bridget Cole Williams, owner of Green Harvest Health, a medical cannabis and life coaching integrative clinic, who aims to address the frustrations of patients with the healthcare system by incorporating plant medicine, particularly cannabis, into treatment approaches. It mentions her experience of transitioning from traditional medicine to a more holistic approach and discusses the creation of the ReclaimMD app, which aims to provide telehealth services.

The article discusses the challenges of cannabis taxation, limits deductions and tax credits for cannabis businesses, creating a punitive tax structure due to federal drug classification in the U.S.. It also emphasizes the need for specialized cannabis accountants and introduction of a turnkey solution, to help businesses navigate the complex tax landscape.

The article provides an update on the status of cannabis legalization at the federal and state levels in the U.S.. It mentions U.S. President Joe Biden administration's pardon of federal possession offenders and the lack of progress on descheduling cannabis. State updates include the approval of cannabis measures in Maryland and Missouri, issues with the industry rollout in New York, the rejection of cannabis legalization in Oklahoma, and delays in implementing legal sales in Virginia.

The article looks at nine significant issues that glaucoma patients should know about the ocular disease. Topics mentioned include a study that looked at patients diagnosed between 1981 and 2000 compared with patients diagnosed between 1965 and 1980 in the same geographic location, the best treatments for glaucoma, and blurred vision or vision loss caused by angle closure glaucoma.

The article discusses the effectiveness of alternative treatments for glaucoma patients. Vitamin supplements that are known to have an effect on glaucoma include B1, B3, B12, C, A and E. In addition, studies have found that gingko can inhibit glutamate cytotoxicity, which leads to ganglion cell death. Other herbal supplements which can have a positive impact include the bilberry plant, forskolin, and medical marijuana.

The article focuses on importance of analytical testing for safety and quality of medical cannabis and its products arrived at dispensaries contaminated with pesticides, residual solvents, and mold. It mentions medical cannabis contains cannabinoids, cannabidiol and hydrocarbons and tests are for impurities and strength of cannabis. It also mentions terpenoids by gas chromatography and cannabis is classified by the U.S. Drug Enforcement Administration as a Schedule I controlled substance.

The article focuses on the journey of introducing therapeutic cannabis use for pets, highlighting the challenges and the progression of allowing veterinarians to discuss and recommend cannabis products for animal patients, along with the emerging research on the effectiveness of cannabis for various pet medical conditions.

The article focuses on the challenges of ensuring regulatory and compliance across international borders in the legal cannabis industry, highlighting the complexities related to product packaging, labeling, cannabinoid levels, and logistical hurdles, and emphasizes the importance of seeking guidance and services from experts specializing in international commerce to navigate these challenges.

The article focuses on Cilo Cybin Pharmaceutical, a medical cannabis company in South Africa, relaunching its plans to list on the Johannesburg Stock Exchange with the support of Malaysian biotechnology firm ALPS Global Holding Berhad, aiming to deliver holistic and individualized health solution.

The article reports on the growing demand for chemists and specialized instruments in the U.S. The trend is attributed to the rising number of new products developed by manufacturers. The Food and Drug Administration (FDA) has approved several products introduced by drug companies. Other companies are developing pharmaceutical-grade cannabis-based products.

The article discusses trends in library security concerns and solutions as libraries flourish with new programs, facilities, and patrons. Topics include patrons' use of tobacco vape pipes to smoke legal marijuana in libraries, panhandlers dressed in religious clothing inside and outside of libraries, and ransomware attacks on servers, payroll systems, or network computers of libraries.

As the legalization of medicinal cannabis continues to sweep across the United States, an urgent need has developed for fast, accurate, and efficient analytical testing. In addition to testing for contaminants and potency, there is also interest in the determination of terpene identity and concentration levels present in different strains of cannabis. Terpenes have been shown to have therapeutic uses for treatment of different medical conditions ranging from cancer and inflammation to anxiety and sleeplessness. It is believed that the combination of terpenes and cannabinoids in cannabis produce a synergistic effect with regards to medical benefits. The traditional testing method for terpenes in plant materials involves a solvent-based extraction followed by gas chromatography (GC) analysis. In this work, headspace solid- phase microextraction (HS-SPME) was used to identify and quantify terpene content in cannabis. The HS-SPME method offered several advantages compared to solvent extraction in that it provided a cleaner analysis, free of interferences from coextracted matrix, and was nondestructive to the sample. A cannabis sample of unknown origin was first analyzed qualitatively by HS-SPME and GC-mass spectrometry (MS). Spectral library matching and retention indices were used to identify 42 terpenes. Quantitative analysis was then performed for several selected terpenes using spiked samples. Method accuracy was >90%, with reproducibility of <5% relative standard deviation (RSD) for analysis of spiked replicates. The HS-SPME results were then compared to an analysis using a conventional solvent extraction method, and the two approaches were found to produce comparable results. [ABSTRACT FROM AUTHOR]

This study focuses on an inductively coupled plasma-mass spectrometry (ICP-MS) sample preparation procedure and analytical methodology optimized for both toxic and nutritional elements in dried hops, a surrogate for the cannabis family of flowering plants. It shows that the wide dynamic range of the technique allows it to be used for the simultaneous determination of parts-per-billion levels of heavy metals including Pb, As, Cd, and Hg, together with high parts-per-million levels of nutritional elements, such as P, Ca, K, and Mg. [ABSTRACT FROM AUTHOR]

Research scientists in the cannabis field are tasked with validating robust methods that can be seamlessly transitioned into production laboratories. Unlike typical disciplines where controls are easily (and legally) obtained through known manufacturers, analytical chemists working for both consumable vendors as well as cannabis laboratories must do their best to develop methods often without such resources at their disposal. As the industry matures and additional regulations are adopted, the evolution of the pesticide testing subsection continues to be vastly different depending on the jurisdiction one does business in. This creates an interesting challenge for commercial scientists tasked with developing methods that will appeal to a majority of their consumers, while also generating unexpected hurdles to said laboratories once the methods are placed into production. This article provides an overview of best practices and method development techniques for pesticide testing in cannabis from a technical perspective. [ABSTRACT FROM AUTHOR]

The article presents information on how to physicians can handle the queries of patients with glaucoma regarding the progressive disease will affect their everyday living. Topics discussed include the treatment and quality-of-life expectations, the therapeutic options like selective laser trabeculoplasty (SLT) and filtration surgery, and the presciption of marijuana.

The article discusses the impact of marijuana culture on the music industry and the use of marijuana by musicians. Topics include rap musician 2 Chainz's interest in getting involved in the cannabis business while advocating for the decriminalization and legalization of marijuana in the U.S., California Lieutenant Governor Gavin Newsom work to pass Proposition 64 legislation to legalize cannabis, and the group Slightly Stoopid's album "Dabbington" made entirely from hashish.

An interview with an author Cathie Hiegel, about her "A Microscopic View of Medical Cannabis" book is presented. Topics discussed include her research on the uses of medical cannabis in medical treatment, her views on how daily use of cannabis with high Tetrahydrocannabinol (THC) levels can cause reversible vasoconstrictive syndrome, and her next books are about anthropology, geology, and physics.

Both benefits and concerns exist, but implementing policies and regulations promotes employee productivity, guards safety. Although marijuana provides health benefits, there are many concerns when it comes to productivity and even safety in the workplace for individuals who use medical marijuana. [Extracted from the article]

The article discusses the concern of the U.S. government whether to ease regulations on drug to advance medical research while maintaining safety issues. Topics discussed include pressurizing the Drug Enforcement Administration for legalizing marijuana, reclassification of drugs from a controlled substance to a less dangerous one, and studying of marijuana and its therapeutic effects.

Fifteen years later when the employee's claim was launched against the firm, the employer stipulated that the employee had experienced a "compensable accident" that led to a workers' compensation claim. An employee of a construction company suffered serious injuries at work and subsequently received a recommendation from his physician that he use medical marijuana. [Extracted from the article]

A decision by the New Jersey Supreme Court allows employees to pursue employment-based discrimination claims if they are terminated for using medical marijuana. A medical marijuana user must satisfy several conditions, and the employer can still take adverse actions in some situations, such as to comply with federal laws or if the employee uses marijuana at the workplace. [Extracted from the article]

The article reports on the Great Britain government's move to legalize the use of cannabis-derived medicinal products to treat those with exceptional clinical needs and discusses how the legalization would affect nurses' role and patient care. Topics mentioned include the restrictions on prescription, the scope of cannabis nursing in the U.S., and the challenges facing British nurses including the need to end the stigma of cannabis.

The transition of cannabis from an illegal drug to a drug for medical and even recreational use raises challenging questions for regulatory agencies and analytical chemists alike. Here, we show a selection of analytical techniques based on compact mass spectrometry (MS) in combination with three different sample inlets (atmospheric solids analysis probe, thin-layer chromatography [TLC], and classical liquid chromatography [LC]) for the detection and quantification of cannabinoids and pesticides in cannabis-related material and contraband. [ABSTRACT FROM AUTHOR]

The article explores the application of intellectual property (IP) protection in the U.S. cannabis industry. It notes that the plant species cannabis is classified under the Controlled Substances Act of 1990 as a Schedule I narcotic with no approved medical use and has a high potential for abuse. Topics include the legalization of marijuana use for recreation and medical purposes in states including Washington, Colorado, and Alaska, the Lanham Act and the Trademark Law, and the Patent Law.

The article discusses in 1970, marijuana has designated a Schedule I drug under the Controlled Substances Act, making impossible for laboratories to perform cannabis research. Topics include medical cannabis and CBD has highlighted the need for good analysis methodology in relatively young market; and cannabis analysis has developing standardized protocols, requirements, and acceptable testing practices.

The article discusses impact of trademark challenges in marijuana industry. Topics discussed include information on challenges for protecting trademarks and other intellectual property (IP) rights for those in the legal marijuana industry; importance of Federal registration which provides a legal presumption of ownership, ensures nationwide protection; and information on Common law trademarks which protect the association of a particular product with its specific supplier or manufacturer.

In 1970, marijuana was designated a Schedule 1 drug, under the Controlled Substances Act, making it nearly impossible for laboratories to perform cannabis research. However, medicinal use of cannabis is now legal in Canada and 33 U.S. states. With the passage of the Farm Bill in 2018, it is now federally legal to grow and process hemp in all 50 states. All of this interest in medical cannabis and cannabidiol (CBD) has highlighted the need for good analysis methodology in this relatively young market. Cannabis analysis is still developing standardized protocols, requirements, and acceptable testing practices. Typical testing requirements for cannabis and its products include analysis of heavy metal, pesticide residues, and the potency of active ingredients such as tetrahydrocannabinol (THC). The terpene content of cannabis is also important. Terpenes have been shown to have beneficial uses for treatment of conditions ranging from cancer and inflammation to anxiety and sleeplessness. It is believed that the combination of terpenes and cannabinoids in cannabis produce a synergistic effect with regards to medical benefits. [ABSTRACT FROM AUTHOR]